Noramco is a world leader in specialty active pharmaceutical ingredients, with a particular focus on controlled substances. The Company’s headquarters and primary production facility is in Wilmington DE, with additional sites in Athens, GA and Neuhausen, Switzerland.

SK Capital acquired Noramco and Extractas Bioscience from Johnson & Johnson in July 2016.

For more information, please visit: www.noramco.com